Cosmetics Production Radiology Regulation 
The Pharma Data
APRIL 15, 2022
director of the FDA’s Center for Devices and Radiological Health. At this level of production, testing capacity using the InspectIR COVID-19 Breathalyzer is expected to increase by approximately 64,000 samples per month. ###. for the next public health emergency.”. The FDA, an agency within the U.S. Source link: [link].
FDA Law Blog
JUNE 28, 2023
Baumhardt, Senior Medical Device Regulation Expert & Philip Won — The Center for Devices and Radiological Health’s (CDRH) Standards and Conformity Assessment Program (S-CAP) encourages medical device sponsors to use FDA-recognized voluntary consensus standards in their product submissions.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
APRIL 20, 2022
director of the FDA’s Center for Devices and Radiological Health. While LDTs are medical devices under the Federal Food, Drug, and Cosmetic Act, the FDA has had a general policy of enforcement discretion for most LDTs since the Medical Device Amendments were enacted in 1976. Source link: [link].
The Pharma Data
NOVEMBER 12, 2021
director of the FDA’s Center for Devices and Radiological Health. “We FDA examinations are designed to include the review and evaluation of records, staff training, installation operations, medical device product and testing, and the systems in place to insure product quality. Source link: [link].
The Pharma Data
NOVEMBER 6, 2020
director of the Office of Neurological and Physical Medicine Devices in the FDA’s Center for Devices and Radiological Health. When Nightware detects that a patient is experiencing a nightmare based on its analysis of heart rate and body movement, the device provides vibrations through the Apple Watch while the product is in use.
pharmaphorum
OCTOBER 4, 2022
On 27th September 2022, the Food and Drug Administration (FDA) issued its final guidance for industry and FDA staff clinical decision support (CDS) software, which has been anticipated since the Center for Devices and Radiological Health (CDRH) listed the guidance as a top priority for fiscal year 2022. Criteria for regulation.
The Pharma Data
MAY 5, 2021
The agency also completed eight mission-critical in-person inspections related to medical devices and radiological health and 10 biologics-related mission-critical inspections. For each regulated commodity, FDA has set forth priorities for inspections ranging from those deemed mission critical, to higher- and lower-priority categories.
Expert insights. Personalized for you.
52 
Let's personalize your content